Elucidating the specific pharmacological system of action (MOA) of Obviously developing compounds can be demanding. While Tarselli et al. (60) designed the primary de novo synthetic pathway to conolidine and showcased that this naturally transpiring compound efficiently suppresses responses to equally chemically induced and inflammation-derived pai